Clascoterone cream 1% is an androgen receptor inhibitor approved for the topical treatment of acne vulgaris (AV) in patients ...

The dosing interval for ixekizumab may be extended in some patients with plaque psoriasis, and switching between biologics may also be considered.

A detailed case study by Dr. Marisa Kassimir, ND, showcasing how homeopathy, nutritional therapy, and lifestyle interventions ...

THE MANAGEMENT of plaque psoriasis has evolved significantly over the past two decades, with biologic treatments becoming ...

The results of an open-label extension study confirmed the interchangeability of biosimilar CT-917 with reference adalimumab for plaque psoriasis.

Healio spoke with Raj Chovatiya, MD, PhD, about results from the phase 3 ICONIC-LEAD trial presented at the 2025 Academy of ...

The following is a summary of “Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT ...

Living with psoriasis presents unique challenges, but with the right skincare routine, you can maintain healthy skin.